Evidence map›Paper›PMID 30535363›Full record

Trial reportThe Journal of infectious diseases2019

Blood Viral Load in Symptomatic Congenital Cytomegalovirus Infection.

Concetta Marsico, Immaculada Aban, Huichien Kuo, Scott H James, Pablo J Sanchez, Amina Ahmed, Ravit Arav-Boger, Marian G Michaels, Negar Ashouri, Janet A Englund and 9 more

Abstract readClinical Trial, Phase IClinical Trial, Phase IIClinical Trial, Phase III
In one paragraph

Trial report in The Journal of infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Risk factors associated with late-onset hearing loss in children with congenital cytomegalovirus: a systematic review.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Human cytomegalovirus and neonatal infection.Current research in microbial sciences · 2024
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Concetta MarsicoNeonatology Unit, Department of Medical and Surgical Sciences, University of Bologna, Italy.
Immaculada AbanDepartment of Biostatistics, Division of Infectious Diseases, University of Alabama at Birmingham.
Huichien KuoDepartment of Biostatistics, Division of Infectious Diseases, University of Alabama at Birmingham.
Scott H JamesDepartment of Pediatrics, Division of Infectious Diseases, University of Alabama at Birmingham.
Pablo J SanchezDepartment of Pediatrics, Divisions of Pediatric Infectious Diseases and Neonatology, Nationwide Children's Hospital - Ohio State University College of Medicine, Columbus.
Amina AhmedDepartment of Pediatrics, Carolinas Medical Center, Charlotte, North Carolina.
Ravit Arav-BogerMedical College of Wisconsin, Milwaukee.
Marian G MichaelsDepartment of Pediatrics, Children's Hospital of Pittsburgh of UPMC, Pennsylvania.
Negar AshouriInfectious Diseases, CHOC Children's Hospital, Orange, California.
Janet A EnglundUniversity of Washington/Seattle Children's Hospital.
Benjamin EstradaUniversity of South Alabama, Mobile.
Richard F JacobsUniversity of Arkansas, Little Rock.
José R RomeroUniversity of Arkansas, Little Rock.
Sunil K SoodSteven and Alexandra Cohen Children's Medical Center, New Hyde Park, New York.
Suzanne WhitworthCook Children's Medical Center, Fort Worth, Texas.
Penelope M JesterDepartment of Pediatrics, Division of Infectious Diseases, University of Alabama at Birmingham.
Richard J WhitleyDepartment of Pediatrics, Division of Infectious Diseases, University of Alabama at Birmingham.
David W KimberlinDepartment of Pediatrics, Division of Infectious Diseases, University of Alabama at Birmingham.
Collaborative Antiviral Study Group (CASG)

Funding

CLINICAL TRIALS FOR ANTIVIRAL THERAPIESN01AI30025 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WHITLEY, RICHARD · 2007 to 2010
$12.8M
Emerging Antiviral Resistance in Congenital Cytomegalovirus InfectionK08AI108691 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI JAMES, SCOTT H · 2014 to 2018
$807k
CLINICAL TRIALS FOR ANTIVIRAL THERAPIES-266030025-266030025N01AI030025 · NIAID · UNIVERSITY OF ALABAMA BIRMINGH · PI WHITLEY, RICHARD R · 2003 to 2006
–
NIAID NIH HHS K08 AI108691NIAID NIH HHS N01AI30025
6 · The paper itself

Abstract

backgroundViral loads (VLs) frequently are followed during treatment of symptomatic congenital cytomegalovirus disease, but their predictive value is unclear.

methodsPost hoc analysis of 2 antiviral studies was performed. Seventy-three subjects were treated for 6 weeks and 47 subjects were treated for 6 months. Whole blood VL was determined by real-time polymerase chain reaction before and during therapy.

resultsHigher baseline VL was associated with central nervous system involvement (3.82 log, range 1-5.65 vs 3.32 log, range 1-5.36; P = .001), thrombocytopenia (3.68 log, range 1-5.65 vs 3.43 log, range 1-5.36; P = .03), and transaminitis at presentation (3.73 log, range 1-5.60 vs 3.39 log, range 1-5.65; P = .009), but with overlap in the amount of virus detected between groups. In subjects treated for 6 months, lower VL at presentation correlated with better hearing outcomes at 12 months, but VL breakpoints predictive of hearing loss were not identified. Sustained viral suppression during 6 months of therapy correlated with better hearing outcomes at 6, 12, and 24 months (P = .01, P = .0007, P = .04), but a majority without viral suppression still had improved hearing.

conclusionsIn infants with symptomatic congenital cytomegalovirus disease, higher whole blood VL before initiation of antiviral therapy has no clinically meaningful predictive value for long-term outcomes.

Indexed as

Viral LoadAdministration, IntravenousAdministration, OralAntiviral AgentsCentral Nervous System DiseasesChild DevelopmentCytomegalovirusCytomegalovirus InfectionsDNA, ViralFemaleGanciclovirHearingHearing LossHumansInfantInfant, NewbornAntiviral AgentsDNA, ViralGanciclovirValganciclovirantiviral therapycongenital CMV infectionhearing lossviral load

Identifiers

PMID30535363
PMCPMC6467187

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.